← Open Payments lookup

LUZVIMINDA NOBLEZA: Open Payments

NPI 1417972167 · INGLEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$82 in 4 payments from 3 companies in 2025. Trend: 2023 $763 · 2024 $454 · 2025 $82

Food & beverage: $82
CompanyPaymentsAmount
Alkermes, Inc.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
ABBVIE INC.1$16

Products named: ARISTADA, CAPLYTA, VRAYLAR.

Industry payments across CA — which companies pay providers there.